{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T18:32:39Z","timestamp":1776882759124,"version":"3.51.2"},"reference-count":25,"publisher":"BMJ","issue":"e1","funder":[{"name":"B. Braun Medical Ltd."},{"name":"EUMEDICA SA Belgium"},{"name":"Australian National Health and Medical Research Council","award":["APP1197866"],"award-info":[{"award-number":["APP1197866"]}]},{"name":"Australian National Health and Medical Research Council","award":["APP2007007, APP2009736"],"award-info":[{"award-number":["APP2007007, APP2009736"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2022,5,3]]},"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1136\/ejhpharm-2022-003286","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T13:20:27Z","timestamp":1653398427000},"page":"e76-e81","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of the stability of temocillin in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy in accordance with the requirements of the UK NHS Yellow Cover Document"],"prefix":"10.1136","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4061-2063","authenticated-orcid":false,"given":"Fekade Bruck","family":"Sime","sequence":"first","affiliation":[{"name":"University of Queensland Centre for Clinical Research, Faculty of Medicine,the University of Queensland, Herston, Queensland, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Wallis","sequence":"additional","affiliation":[{"name":"University of Queensland Centre for Clinical Research, Faculty of Medicine,the University of Queensland, Herston, Queensland, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conor","family":"Jamieson","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, West Midlands, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Hills","sequence":"additional","affiliation":[{"name":"Pharmacy Department and OPAT Service, Nottingham University Hospitals, Nottingham, UK, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Gilchrist","sequence":"additional","affiliation":[{"name":"Department of Pharmacy\/Infection, Imperial College Healthcare NHS Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Santillo","sequence":"additional","affiliation":[{"name":"Quality Assurance, University Hospitals Plymouth NHS Trust, Plymouth, UK and University Hospitals Bristol and Weston NHS Trust, Bristol, UK, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R Andrew","family":"Seaton","sequence":"additional","affiliation":[{"name":"Queen Elizabeth University Hospital, Glasgow, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felicity","family":"Drummond","sequence":"additional","affiliation":[{"name":"British Society for Antimicrobial Chemotherapy, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Roberts","sequence":"additional","affiliation":[{"name":"University of Queensland Centre for Clinical Research, Faculty of Medicine,the University of Queensland, Herston, Queensland, Australia"},{"name":"Herston Infectious Diseases Institute (HeIDI), Metro North Health, Brisbane, Queensland, Australia"},{"name":"Departments of Pharmacy and Intensive Care Medicine, Royal Brisbane and Women\u2019s Hospital, Brisbane, Queensland, Australia"},{"name":"Division of Anaesthesiology Critical Care Emergency and Pain Medicine, N\u00eemes University Hospital, University of Montpellier, N\u00eemes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,5,24]]},"reference":[{"key":"2025090702500608000_30.e1.e76.1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.20.1.38"},{"key":"2025090702500608000_30.e1.e76.2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.22.3.453"},{"key":"2025090702500608000_30.e1.e76.3","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn511"},{"key":"2025090702500608000_30.e1.e76.4","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl043"},{"key":"2025090702500608000_30.e1.e76.5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106223","article-title":"Temocillin susceptibility in Enterobacterales with an ESBL\/AmpC phenotype","volume":"57","author":"Kresken","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"2025090702500608000_30.e1.e76.6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s40262-017-0584-7","article-title":"Pharmacokinetics and pharmacodynamics of Temocillin","volume":"57","author":"Alexandre","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"2025090702500608000_30.e1.e76.7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2217\/fmb-2018-0316","article-title":"Temocillin: is this the right momentum for its global use?","volume":"14","author":"Balakrishnan","year":"2019","journal-title":"Future Microbiol"},{"key":"2025090702500608000_30.e1.e76.8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S1473-3099(21)00407-2","article-title":"The clinical and microbiological efficacy of temocillin versus cefotaxime in adults with febrile urinary tract infection, and its effects on the intestinal microbiota: a randomised multicentre clinical trial in Sweden","volume":"22","author":"Edlund","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2025090702500608000_30.e1.e76.9","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq152"},{"key":"2025090702500608000_30.e1.e76.10","first-page":"21","article-title":"Outpatient parenteral antimicrobial therapy (OPAT) in Christchurch: 18 years on","volume":"132","author":"Chambers","year":"2019","journal-title":"New Zeal Med J"},{"key":"2025090702500608000_30.e1.e76.11","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2015-309731"},{"key":"2025090702500608000_30.e1.e76.12","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1093\/jac\/dkaa248","article-title":"Monte Carlo simulation of temocillin 6\u2009g daily administered by continuous infusion or intermittent dosage","volume":"75","author":"Tsakris","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2025090702500608000_30.e1.e76.13","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s10096-015-2406-x","article-title":"Amoxicillin plus temocillin as an alternative empiric therapy for the treatment of severe hospital-acquired pneumonia: results from a retrospective audit","volume":"34","author":"Habayeb","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2025090702500608000_30.e1.e76.14","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm467"},{"key":"2025090702500608000_30.e1.e76.15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s15010-020-01398-4","article-title":"Efficacy and safety of a Belgian tertiary care outpatient parenteral antimicrobial therapy (OPAT) program","volume":"48","author":"Quintens","year":"2020","journal-title":"Infection"},{"key":"2025090702500608000_30.e1.e76.16","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ijantimicag.2018.05.001","article-title":"Continuous beta-lactam intravenous antibiotic infusions for outpatient parenteral antimicrobial therapy","volume":"52","author":"Habayeb","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"2025090702500608000_30.e1.e76.17","unstructured":"NHS . A Standard Protocol for Deriving and Assessment of Stability Part 1- Aseptic Preparations (Small Molecules) NHS Pharmaceutical Research and Development Working Group, 2019."},{"key":"2025090702500608000_30.e1.e76.18","doi-asserted-by":"crossref","first-page":"dkw556","DOI":"10.1093\/jac\/dkw556","article-title":"Extended stability of antimicrobial agents in administration devices","volume":"72","author":"Jenkins","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2025090702500608000_30.e1.e76.19","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq229"},{"key":"2025090702500608000_30.e1.e76.20","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s10337-014-2741-6","article-title":"Analysis of Temocillin and impurities by reversed phase liquid chromatography: development and validation of the method","volume":"77","author":"Kahsay","year":"2014","journal-title":"Chromatographia"},{"key":"2025090702500608000_30.e1.e76.21","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pharma.2011.09.004","article-title":"Long-term stability of temocillin in dextrose 5% and in sodium chloride 0.9% polyolefin bags at 5 \u00b1 3\u00b0C after freeze-thaw treatment","volume":"69","author":"Rolin","year":"2011","journal-title":"Ann Pharm Fr"},{"key":"2025090702500608000_30.e1.e76.22","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.2042-7158.1986.tb04485.x","article-title":"The degradation of temocillin, a 6 alpha-methoxypenicillin, and identification of the major degradation products","volume":"38","author":"Burton","year":"1986","journal-title":"J Pharm Pharmacol"},{"key":"2025090702500608000_30.e1.e76.23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/jppr.1422","article-title":"Extended duration infusion temperatures in the tropics: 2 (EDITT2)","volume":"48","author":"Perks","year":"2018","journal-title":"Journal of Pharmacy Practice and Research"},{"key":"2025090702500608000_30.e1.e76.24","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp151071"},{"key":"2025090702500608000_30.e1.e76.25","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.3.4.463"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2022-003286","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T09:50:15Z","timestamp":1757238615000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2022-003286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,24]]},"references-count":25,"journal-issue":{"issue":"e1","published-online":{"date-parts":[[2023,3,19]]},"published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.1136\/ejhpharm-2022-003286"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2022-003286","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,24]]}}}